|
|
Post by LongMNKD on Sept 4, 2015 18:31:56 GMT -5
Just when you think things are starting to look up.
|
|
|
|
Post by mannmade on Sept 4, 2015 18:35:56 GMT -5
MannKind Corporation MannKind Announces Renewal of Shelf Registration and ATM Agreements VALENCIA, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and Exchange Commission, replacing the previous shelf which expired on August 31, 2015. Concurrently, MannKind also renewed its At-The-Market Issuance Sales Agreements with Meyers Associates, L.P. (now doing business as BP Capital, a division of Meyers Associates, L.P.) and with MLV & Co. LLC providing for sales, from time to time, of the Company's common stock. About MannKind Corporation MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. CONTACT: Company Contact: Matthew J. Pfeffer Chief Financial Officer 661-775-5300 mpfeffer@mannkindcorp.co MannKind Corporation Logo Source: MannKind Corporation You are subscribed to MannKind Corporation Investor Relations' e-mail alerts as daw12@me.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. MannKind Corporation 28903 North Avenue Paine , Valencia, CA 91355 Service provided by Shareholder.com |
|
|
|
Post by liane on Sept 4, 2015 18:37:18 GMT -5
Looks like the After Hours Market does not like what ever it is. After hours volume is only 144,427 - relatively insignificant. |
|
|
|
Post by tbone on Sept 4, 2015 18:54:24 GMT -5
MannKind Corporation MannKind Announces Renewal of Shelf Registration and ATM Agreements VALENCIA, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and Exchange Commission, replacing the previous shelf which expired on August 31, 2015. Concurrently, MannKind also renewed its At-The-Market Issuance Sales Agreements with Meyers Associates, L.P. (now doing business as BP Capital, a division of Meyers Associates, L.P.) and with MLV & Co. LLC providing for sales, from time to time, of the Company's common stock. About MannKind Corporation MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. CONTACT: Company Contact: Matthew J. Pfeffer Chief Financial Officer 661-775-5300 mpfeffer@mannkindcorp.co MannKind Corporation Logo Source: MannKind Corporation You are subscribed to MannKind Corporation Investor Relations' e-mail alerts as daw12@me.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. MannKind Corporation 28903 North Avenue Paine , Valencia, CA 91355 Service provided by Shareholder.com Yep. Another over reaction to nothing. |
|
|
|
Post by od on Sept 4, 2015 18:56:21 GMT -5
Note the choppy afterhour trade. Perhaps a Short trap to throw them off. Get in deeper as our scripts rise, insurance tier grows, & marketing spends accelerates. Relax, we saw some progress today in scripts and there is simply insufficient data to cause any anxiety for the holiday weekend. I cannot imagine my passion for Afrezza will disappoint. That said, I don't understand all the positive comments on today's Symphony data. TRxs increased logically. NRxs suggest a stagnant prescriber base. Yes, it is great to see TRxs confirm patient's positive response to Afrezza, but NRxs are key. I remain relaxed because I stopped drinking my own Kool Aid shortly after launch and got real. MNKD is a keeper. |
|
|
|
Post by mannmade on Sept 4, 2015 18:58:07 GMT -5
With the exception of the current price which no rational mind in their wildest dreams could forecast after FDA approval except perhaps a short w access to dirty tricks I would like to remind everyone that mnkd mgmt has been good to their word the past twoor three years on everything they said and told us to expect at the time mentioned. I have no reason to doubt them now so I do not worry about significant dilution at this time nor do I speculate what the filings mean. Just mho...
|
|
|
|
Post by bradleysbest on Sept 4, 2015 19:07:37 GMT -5
Agree although it is easier said then done! Have a great weekend all longs!
|
|
|
|
Post by kc on Sept 4, 2015 19:20:17 GMT -5
Perhaps Alfred Mann will be purchasing additional shares? perhaps Sanofi will be exchanging their note with MannKind for new Non-registered shares. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 4, 2015 19:37:16 GMT -5
With the exception of the current price which no rational mind in their wildest dreams could forecast after FDA approval except perhaps a short w access to dirty tricks I would like to remind everyone that mnkd mgmt has been good to their word the past twoor three years on everything they said and told us to expect at the time mentioned. I have no reason to doubt them now so I do not worry about significant dilution at this time nor do I speculate what the filings mean. Just mho... I have listened to several earnings and investment conference calls and to date there has been no surprises. I did have a couple of questions of events, however, Matt answered my inquiries to my satisfaction. I have listened to many executives, most are unimpressive, Matt is an exception. If you are questioning your purchase of MannKind, I recommend going back and listening to conference calls; it will build your confidence in MannKind. |
|
|
|
Post by kc on Sept 4, 2015 19:46:55 GMT -5
With the exception of the current price which no rational mind in their wildest dreams could forecast after FDA approval except perhaps a short w access to dirty tricks I would like to remind everyone that mnkd mgmt has been good to their word the past twoor three years on everything they said and told us to expect at the time mentioned. I have no reason to doubt them now so I do not worry about significant dilution at this time nor do I speculate what the filings mean. Just mho... I have listened to several earnings and investment conference calls and to date there has been no surprises. I did have a couple of questions of events, however, Matt answered my inquiries to my satisfaction. I have listened to many executives, most are unimpressive, Matt is an exception. If you are questioning your purchase of MannKind, I recommend going back and listening to conference calls; it will build your confidence in MannKind. Especially the Bank of America call back in May. It might be worth reviewing that one as it might tell us his game plan. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 5, 2015 5:40:51 GMT -5
The S-3ASR is an automatic shelf registration statement which is immediately effective upon filing for use by well-known seasoned issuers to register unspecified amounts of different specified types of securities. This Registration Statement is for the registration of securities under the Securities Act of 1933. Edit: I really don't get it though, the excel spreadsheet posted on the mannkind investor's page doesn't have any details.. -1 for number of warrants issued etc. Any chance this is basically a shelf offering to be used when share price is high enough so as not to dilute and in the interim, you know who loans the company money and gets his $ back via this offering when SP is high enough? "We may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to $50,000,000, from time to time through MLV or BP Capital, whom we collectively refer to herein as the Agents, as our sales agents provided that in no event will we sell more than 25,000,000 shares in this offering." |
|
|
|
Post by mnholdem on Sept 5, 2015 8:58:29 GMT -5
MannKind Corporation MannKind Announces Renewal of Shelf Registration and ATM Agreements VALENCIA, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and Exchange Commission, replacing the previous shelf which expired on August 31, 2015. Concurrently, MannKind also renewed its At-The-Market Issuance Sales Agreements with Meyers Associates, L.P. (now doing business as BP Capital, a division of Meyers Associates, L.P.) and with MLV & Co. LLC providing for sales, from time to time, of the Company's common stock. ... Matthew J. Pfeffer Chief Financial Officer Yep. Another over reaction to nothing. spiro, if you've been under your desk, curled in a fetal position again, I think you can come out now...  |
|
|
|
Post by dreamboatcruise on Sept 5, 2015 13:20:37 GMT -5
The S-3ASR is an automatic shelf registration statement which is immediately effective upon filing for use by well-known seasoned issuers to register unspecified amounts of different specified types of securities. This Registration Statement is for the registration of securities under the Securities Act of 1933. Edit: I really don't get it though, the excel spreadsheet posted on the mannkind investor's page doesn't have any details.. -1 for number of warrants issued etc. Any chance this is basically a shelf offering to be used when share price is high enough so as not to dilute and in the interim, you know who loans the company money and gets his $ back via this offering when SP is high enough? "We may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to $50,000,000, from time to time through MLV or BP Capital, whom we collectively refer to herein as the Agents, as our sales agents provided that in no event will we sell more than 25,000,000 shares in this offering."Certainly it's possible that the share price will go up. However, on the face of it this shelf offering seems to indicate they think they will need money and that they may raise it at share prices as low as $2 on average. So there is always a chance, but the document indicates management doesn't not have conviction in that scenario. mnholdem... I don't see Spiro under this desk. Maybe he's under a different one. |
|
|
|
Post by savzak on Sept 5, 2015 15:23:27 GMT -5
Any chance this is basically a shelf offering to be used when share price is high enough so as not to dilute and in the interim, you know who loans the company money and gets his $ back via this offering when SP is high enough? "We may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to $50,000,000, from time to time through MLV or BP Capital, whom we collectively refer to herein as the Agents, as our sales agents provided that in no event will we sell more than 25,000,000 shares in this offering."Certainly it's possible that the share price will go up. However, on the face of it this shelf offering seems to indicate they think they will need money and that they may raise it at share prices as low as $2 on average. So there is always a chance, but the document indicates management doesn't not have conviction in that scenario. mnholdem... I don't see Spiro under this desk. Maybe he's under a different one. Was the prior registration that just expired also worded such as to permit the sale of 50,000,000 shares as low as $2? If the re-registration is identical to the expired registration, I don't see any downside. It would be nice if MNKD were in the position to let it lapse but the reality is, it is not. There's no sense in management being cavalier about the current financial state, throwing caution to the wind and pretending like there's no possibility the registration will ever be needed. And let's face it, if management didn't re-file upon expiration, but did so 2 or 3 months from now, the negative impression would be amplified by orders of magnitude. |
|
|
|
Post by mnholdem on Sept 5, 2015 18:56:45 GMT -5
Smart, prudent management decision to keep an ATM in place. It's like many wise people who keep money in the bank or a line of credit (which I keep) for emergency uses - the tranny goes out in your vehicle, your furnace/air conditioning breaks down. Unexpected things happen. Like the original ATM, MannKind may not need $50M but it's smart to have it in reserve.
|
|
